Safety of combining erythropoietin and melatonin for very preterm infants with brain bleeds
Official title: Safety of Combinatorial Therapy with Erythropoietin and Melatonin for Preterm Infants with Intraventricular Hemorrhage
Funded at Johns Hopkins University · NIH-11105816 · Data updated 2026-11-12
A Johns Hopkins team is testing a combination of melatonin and erythropoietin to help very preterm babies who have intraventricular hemorrhage avoid longer-term brain problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | June 3, 2022 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $576,385 |
| NIH project number | 5R01HD104673-04 |
| Project ID | NIH-11105816 on NIH RePORTER |
Who could benefit from this research
✓Could help
Very preterm infants with intraventricular hemorrhage and risk of progressing to hydrocephalus.
✕Less likely to help
Infants without IVH-related brain injury or those not at risk for PHH may not benefit.
What this research studies
This project focuses on babies born very early who are at high risk for serious brain injury after intraventricular hemorrhage. Researchers are exploring whether giving two safe, familiar medicines together can influence how the brain and its fluid system develop and reduce the need for surgical treatment later on. The study builds on preclinical data showing potential benefits when the medications are given in a steady dosing pattern. If successful, this approach could offer a medical option to protect brain development and possibly reduce complications like hydrocephalus.
Why it matters
Potential benefit: If effective, the combination therapy could lessen the chance of needing brain surgery and improve long-term neurodevelopment in very preterm infants.
How similar studies have gone: Preclinical data suggest the combination can prevent progression from sIVH to PHH in animal models, but human data are needed.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Robinson, Shenandoah — Johns Hopkins University
- Study coordinator: Robinson, Shenandoah
Related research
Other NIH-funded projects on the same topics.
-
Brain fluid buildup and brain wiring after bleeding in very premature babies
Sees if larger fluid-filled spaces and changes in brain connections are linked to thinking and movement problems in very premature babies who had brain bleeding.
-
Understanding epilepsy risk in very preterm infants with brain hemorrhage
This study is looking at how very premature babies who have serious bleeding in the brain might develop epilepsy and other developmental challenges, and it aims to find early signs that could help doctors identify these risks so they can provide better care and support for these little ones.
-
Impact of brain fluid volume on neurological outcomes in preterm infants with bleeding
This study looks at how the amount of fluid in the brains of very preterm babies with brain bleeding affects their development and thinking skills, with the hope of finding ways to help them grow and learn better.
-
Investigating the role of mural stem cells in brain development and hemorrhage in preterm infants
This study is looking at how special cells in the brain help form blood vessels, especially in preterm babies who might have bleeding in the brain, to better understand their development and find new ways to help them.
-
Wearable tech to track blood loss during childbirth
A wearable device monitors cardiovascular signals to detect postpartum hemorrhage early so clinicians can act quickly to protect mothers.
-
SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers
This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.